Since MAP4K4 was at the upstream of SOX6-induced autophagy, its inhibitor might be more specific in inhibiting autophagy and subsequently increasing the sensitivity of cervical cancer cells to cisplatin chemotherapy. Here, MAP4K4 is linked to cervical carcinoma.